Home Compare REGN vs VRSK
Stock Comparison · Structural lead, mixed market

Regeneron Pharmaceuticals vs Verisk Analytics: Which Stock Looks Stronger in 2026?

Verisk Analytics holds the cleaner structural position, with the lead spread across growth and profitability. Regeneron Pharmaceuticals still leads on valuation and stability, which keeps the comparison from looking entirely one-sided. In the market, Regeneron Pharmaceuticals carries the stronger setup — intact trend against Verisk Analytics's broken trend. That leaves a split case: the structural lead stays with Verisk Analytics, but the market is not currently confirming it.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The lead is spread across growth and profitability, rather than sitting in one isolated gap. The overall score gap is 14 points in favour of Verisk Analytics, Inc..

Trajectory Similarity
0.63
Moderately similar
Peer-set rank: #5
within Regeneron Pharmaceuticals, Inc.'s functional peer set

This pair is matched through long-term financial trajectory similarity within the selected peer universe.

A moderate similarity means the pair is structurally comparable, but not a near-twin trajectory match.

The clearest structural overlap shows up in margin trend and revenue stability.

Similarity drivers
margin trendrevenue stability
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
REGN
Regeneron Pharmaceuticals, Inc.
61
Peer-Score
Signal qualityHigh
vs
VRSK
Verisk Analytics, Inc.
75
Peer-Score
Signal qualityMedium

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The largest gaps do not all point in the same direction.

Dimension spread: REGN vs VRSK Profitability 63 100 Stability 65 53 Valuation 80 69 Growth 22 67 REGN VRSK
Gap Ranking
#1 Growth +45
#2 Profitability +37
#3 Stability +12
#4 Valuation +11
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for REGN and VRSK Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer REGNVRSK Relative valuation Structural strength

The price setup looks more supportive for Verisk Analytics, Inc., but Regeneron Pharmaceuticals, Inc. still has the stronger structure.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Growth
On growth, Verisk Analytics, Inc. ranks near the top of the group; Regeneron Pharmaceuticals, Inc. sits in the weaker half.
Profitability
On profitability, the edge is clear — both rank well, but Verisk Analytics, Inc. sits noticeably higher.
Growth — Dominant Gap
REGN
22
VRSK
67
Gap+45in favour of VRSK

The current lead is backed by a stronger multi-year growth trajectory.

What keeps the gap from being one-sided

On the market side, Regeneron Pharmaceuticals carries the stronger trend while Verisk Analytics's trend has broken — the market setup does not confirm the structural advantage.

What this means for the comparison

The lead is built on both growth and profitability — though valuation still provides a counterweight.

Explore full peer positioning in AssetNext

Break down the REGN vs VRSK comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar growth-and-profitability comparisons

Explore how REGN and VRSK each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.